跳至主要内容
临床试验/NCT00312325
NCT00312325已完成4 期

Effect of High-Dose Prednisolone (Solu Dacortin®) Treatment on Choroidal and Optic Nerve Head Blood Flow in Humans

Medical University of Vienna2 个研究点 分布在 1 个国家目标入组 24 人开始时间: 2005年7月最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
24
试验地点
2
主要终点
Non invasive measurement of optic nerve and choroidal blood flow

研究概览

简要总结

Because of their antiinflamatory effects, glucocorticoids are often used to reduce edema in neurologic tissue and to otherwise mitigate the consequences of neural inflammation. For example, high dose prednisolone treatment has been shown to be an effective therapy for different eye diseases including severe Graves´ Ophthalmopathy and acute optic neuritis. However, contradictory results exists for the influence of high dose prednisolone therapy per se on tissue blood flow. Thus, in the current study, we plan to investigate the effect of high dose, short time therapy with intravenous prednisolone in patients with optic neuritis and severe Graves´ Ophthalmopathy.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
19 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Men and women aged between 19 and 65 years, nonsmokers
  • Group A: Patients with Graves´ Ophthalmopathy (moderate to severe and active ophthalmopathy; i.e. clinical activity score >3 or =3) suitable for high-dose treatment with prednisolone as assessed by an independent ophthalmologist
  • Group B: Patients with acute onset of optic neuritis suitable for high-dose treatment with prednisolone suitable for high-dose treatment with prednisolone as assessed by the ophthalmologist
  • Normal laboratory values unless the investigator considers an abnormality to be clinically irrelevant and not to interfere with prednisolone treatment (normal liver blood parameter and hepatitis serology).
  • Ametropy of less than 3 dpt.

排除标准

  • Regular use of medication which could interfere with the study objectives, especially treatment with vasoactive drugs
  • Active peptic ulcer or insulin dependent diabetes mellitus
  • Hepatitis or elevated hepatic blood parameters
  • Abuse of alcoholic beverages, participation in a clinical trial in the 3 weeks preceding the study
  • Symptoms of a clinically relevant illness in the 3 weeks before the first study day
  • Blood donation during the previous 3 weeks
  • Pregnancy

结局指标

主要结局

Non invasive measurement of optic nerve and choroidal blood flow

次要结局

未报告次要终点

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验